CCDR: Volume 48-7/8, July/August 2022: Healthcare-Associated Infections & Antimicrobial Resistance

Table of contents

Overview
Counterfactuals of effects of vaccination and public health measures on COVID-19 cases in Canada: What could have happened?
NH Ogden, P Turgeon, A Fazil, J Clark, V Gabriele-Rivet, T Tam, V Ng

Surveillance
Laboratory-acquired infections in Canada from 2016 to 2021
M El Jaouhari, M Striha, R Edjoc, S Bonti-Ankomah

Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2016–2020
Canadian Nosocomial Infection Surveillance Program

Device and surgical procedure-related infections in Canadian acute care hospitals from 2011 to 2020
Canadian Nosocomial Infection Surveillance Program

Scoping Review
National healthcare-associated infections surveillance programs: A scoping review
E Poirier, V Boulanger, A MacLaurin, C Quach

Epidemiologic Study
Multivariate analyses of risk factors associated with laboratory exposure incidents
M El Jaouhari, N Atchessi, R Edjoc, M Striha, S Bonti-Ankomah

Qualitative Study
Compliance with COVID-19 preventive measures is high among university-level students in Québec, Canada
Y Pilon, R Turcitu, R Allard

Rapid Communication
Summary of the National Advisory Committee on Immunization (NACI) statement update on the recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants
D Moore, A Sinilaite, A Killikelly; on behalf of the National Advisory Committee on Immunization (NACI)

Summary of the National Advisory Committee on Immunization (NACI) Rapid Response—Interim guidance on the use of Imvamune in the context of monkeypox outbreaks in Canada
A Killikelly, N Brousseau on behalf of the National Advisory Committee on Immunization (NACI)

COVID Brief
What do people think about COVID-19 booster doses?